approved glp 1 agonists Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Medications for Weight Loss:

Patients with diabetes already face a higher risk of atrial fibrillation, so understanding how these GLP-1 receptor agonists affect cardiac electrophysiology is essential

GLP-1RA use and thyroid cancer risk

doi: 10.1161/CIRCULATIONAHA.111.041418 33 ShirakawaJFujiiHOhnumaKSatoKItoYKajiMet al

Owing to intrinsic limitations of network meta-analysis, we avoided to analyze the effects of these drugs in several subgroupse.g., as stratified by age or the presence of CV disease or type 2 diabetesto avoid type 1 error due to the many subgroup analyses

Behind the scenes, researchers are studying several new injectable medications that work in similar ways

Glucagon-like peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study